Alyeska Investment Group’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-908,107
| Closed | -$8.91M | – | 554 |
|
|
2023
Q4 | $8.91M | Sell |
908,107
-1,195,862
| -57% | -$11.7M | 0.06% | 266 |
|
|
2023
Q3 | $17.6M | Buy |
2,103,969
+174,883
| +9% | +$1.46M | 0.12% | 213 |
|
|
2023
Q2 | $25.7M | Buy |
1,929,086
+844,702
| +78% | +$11.2M | 0.19% | 160 |
|
|
2023
Q1 | $12.6M | Buy |
+1,084,384
| New | +$12.6M | 0.11% | 218 |
|
|
2022
Q4 | – | Sell |
-700,000
| Closed | -$4.06M | – | 487 |
|
|
2022
Q3 | $4.06M | Buy |
+700,000
| New | +$4.06M | 0.05% | 273 |
|
|
2022
Q1 | – | Sell |
-173,885
| Closed | -$3.56M | – | 644 |
|
|
2021
Q4 | $3.56M | Sell |
173,885
-221,439
| -56% | -$4.53M | 0.04% | 344 |
|
|
2021
Q3 | $10.1M | Sell |
395,324
-336,029
| -46% | -$8.59M | 0.12% | 195 |
|
|
2021
Q2 | $25.6M | Buy |
731,353
+406,353
| +125% | +$14.2M | 0.3% | 101 |
|
|
2021
Q1 | $10.8M | Sell |
325,000
-523,216
| -62% | -$17.4M | 0.14% | 183 |
|
|
2020
Q4 | $22M | Sell |
848,216
-651,784
| -43% | -$16.9M | 0.31% | 98 |
|
|
2020
Q3 | $14.8M | Buy |
+1,500,000
| New | +$14.8M | 0.23% | 139 |
|
|
2019
Q4 | – | Sell |
-1,281,676
| Closed | -$6.61M | – | 437 |
|
|
2019
Q3 | $6.61M | Sell |
1,281,676
-39,466
| -3% | -$204K | 0.1% | 189 |
|
|
2019
Q2 | $7.99M | Sell |
1,321,142
-628,858
| -32% | -$3.8M | 0.1% | 184 |
|
|
2019
Q1 | $14.1M | Sell |
1,950,000
-2,494,770
| -56% | -$18M | 0.19% | 137 |
|
|
2018
Q4 | $32.9M | Buy |
+4,444,770
| New | +$32.9M | 0.48% | 71 |
|
|
2017
Q3 | – | Sell |
-600,000
| Closed | -$2.14M | – | 487 |
|
|
2017
Q2 | $2.14M | Buy |
+600,000
| New | +$2.14M | 0.02% | 327 |
|
|
2017
Q1 | – | Sell |
-494,100
| Closed | -$1.88M | – | 517 |
|
|
2016
Q4 | $1.88M | Buy |
+494,100
| New | +$1.88M | 0.02% | 380 |
|